Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
East China Normal University maintains a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The university currently has 5 pending office actions. These actions are distributed among 5 distinct examiners, indicating a broad range of individual reviews. Furthermore, the prosecution activity spans 4 distinct art units, suggesting a diverse set of biological or pharmaceutical innovations. This breadth of examination indicates that the university's research output is being scrutinized by several specialized groups within the patent office.
MOAZZAMI, NAGHMEH NINA is the busiest examiner for the portfolio, currently managing 1 busiest examiner pending action. Because there are 5 pending office actions and 5 distinct examiners, the workload is perfectly distributed, with each examiner handling exactly one action. The involvement of 4 distinct art units highlights the multidisciplinary nature of the university's research within the biotechnology sector. Practitioners should be prepared for varied feedback, as the 5 distinct examiners across 4 distinct art units likely bring different perspectives to the 5 pending office actions.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 1 (20%) |
| §112 only | 1 (20%) |
| Multi-statute (no §101) | 2 (40%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOAZZAMI, NAGHMEH NINA | 1 | 72.0% | +49.3% |
| ZAHORIK, AMANDA MARY | 1 | 57.8% | +49.0% |
| CUTLIFF, YATE KAI RENE | 1 | 79.8% | +24.3% |
| BAKSHI, PANCHAM | 1 | 76.8% | +30.2% |
| SYLVESTER, KEVIN | 1 | 47.5% | +27.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 14d |
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | — |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18135893 | CONSTRUCTION METHOD AND APPLICATION OF MICROTUBE-BASED IONIC LIQUID COLLOID/WATER INTERFACE | CUTLIFF, YATE KAI RENE | 142d overdue |
| 17724569 | ELECTRODE MATERIAL AND PREPARATION METHOD THEREOF | SYLVESTER, KEVIN | 12d |
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 14d |
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | — |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | — |
| Art Unit | Apps |
|---|---|
| 1652 | 1 |
| 1692 | 1 |
| 1623 | 1 |
| 1794 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18747728 | USE OF SNAT2 COMPETITIVE INHIBITOR OR GENE EXPRESSION INHIBITION IN THE PREPARATION OF DRUGS FOR THE PREVENTION AND/OR TREATMENT OF HYPERTENSION | MOAZZAMI, NAGHMEH NINA | 1652 | §103§112 | Non-Final OA | — | Pending | Jun 19, 2024 |
| 18686437 | Base Editing System for Achieving A-To-C and/or A-To-T Base Mutations and Use Thereof | ZAHORIK, AMANDA MARY | — | §101§102§103§112 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18135893 | CONSTRUCTION METHOD AND APPLICATION OF MICROTUBE-BASED IONIC LIQUID COLLOID/WATER INTERFACE | CUTLIFF, YATE KAI RENE | 1692 | §112 | Non-Final OA | 142d overdue | Pending | Apr 18, 2023 |
| 18031243 | FUNCTIONALIZED FLUOROALKYL SILANE, AND SYNTHETIC METHOD THEREFOR AND APPLICATION THEREOF | BAKSHI, PANCHAM | 1623 | §103§112 | Final Rejection | 14d | Pending | Apr 11, 2023 |
| 17724569 | ELECTRODE MATERIAL AND PREPARATION METHOD THEREOF | SYLVESTER, KEVIN | 1794 | §103 | Non-Final OA | 12d | Pending | Apr 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial